Cue Biopharma Inc (NAS:CUE)
$ 28.33 -0.080 (-0.28%) Market Cap: 119.00 Mil Enterprise Value: 106.06 Mil PE Ratio: 0 PB Ratio: 4.27 GF Score: 59/100

Cue Biopharma Inc at Jefferies Global Healthcare Conference in New York Transcript

Jun 03, 2026 / 07:10PM GMT
Release Date Price: $26.91 (-5.97%)
Amin Makarem
Jefferies LLC - Equity Analyst

Hello, everyone. Thanks for being here. I'm Amin Makarem, one of the biotech analysts here at Jefferies.

I'm happy to introduce and welcome Shao-Lee Lin, CEO of Cue Biopharma.

This is a standard presentation format, and with that, I'll hand it over to Shao.

Shao;Lee Lin
Cue Biopharma Inc - President, Chief Executive Officer, Director

Thank you so much for the introduction, Amin, and thanks, Jefferies, for the opportunity for us to present at your conference. Here are our forward-looking statements, which I'm sure you'll all study. It is an incredibly exciting time for us at Cue.

Over the past year, I've been actively drug hunting for transformational therapies alongside a small and highly experienced team. Throughout my career, both in big pharma and smaller biotech, I found that among many promising programs that one might find in a given year, only one or two actually have the potential to fundamentally change outcomes for patients.

When we began this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot